Foreign genes have been introduced into mammalian cells (1, 2) , and gene therapy has been evaluated as a possible option in patients for treatment of certain inherited diseases (3, 4) . Retroviral-vectors have been used most often to stably transduce genes into cells, and targets for these genes have included hematopoietic stem/progenitor cells (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , lymphocytes (21), and tumor cells (22) . Hematopoietic stem and progenitor cells are found in low frequency in blood forming tissue, but it is these rare cells that present a viable target for gene therapy. In humans, although antigenic determinants specific for stem and progenitor cells have not yet been identified, these cells contain CD34 antigens and this antigenic determinant has been used successfully as a marker to highly enrich stem and progenitor cells in human adult bone marrow (23-25), blood (20), and umbilical cord blood (25). 2089 Cord blood, which contains hematopoietic stem/progenitor cells at afrequency equal to or greater than that ofadult bone marrow (26) (27) (28) (29) and has a high quality for proliferation (26) (27) (28) (29) and self-renewal (25, 30, 31) has shown promise clinically, as an alternative source ofhuman transplantable and marrow repopulating cells (32) (33) (34) (35) (36) . Recently, it has been demonstrated that cord blood progenitors and long-term culture initiating cells present in a relatively unseparated population of cells are more efficiently transduced by retroviral-mediated gene transfer than are these cells in adult bone marrow (37) . For logistic reasons, including the amount of viral supernatant available for gene transduction, purified populations of human stem, and progenitor cells will most likely serve increasingly as targets for future clinical gene therapy procedures. In this context, cord blood is an interesting choice for this source of cells especially for autologous transplantation for in uterodiagnosed genetic disorders. For these reasons we chose to evaluate the efficiency of retroviral-mediated gene transduction into highly enriched populations of human cord blood stem and progenitor cells. Future insights will no doubt allow for antigenic characterization of distinct subsets of stem and progenitor cells differing in capacity for self-renewal, proliferation, and lineage-specific differentiation that could potentially be used for selective transplantation. Since the growth of isolated single cell-sorted human stem/progenitor cells is possible (25, 38, 39) , we also evaluated the capacity to transduce genes into single isolated CD343 + cord blood cells with extensive replating capacity (a measure of self-renewal). We show that populations of CD343 + cord blood high proliferative potential colony forming cells (HPP-CFC)1 , and multipotential CFU-granulocyte erythroid macrophage megakaryocyte (GEMM), burst forming unit-erythroid (BFU-E), and CFU-granulocyte-macrophage (GM) progenitor cells can be retrovirally transduced with a TK-neo gene at very high efficiency. This is accomplished also at the single isolated CD343 + cell level, with the gene stably integrated into cells with high replating capacity.
Materials and Methods
Cells and Cell Separation. Cells were obtained from normal human umbilical cord blood scheduled for discard after delivery of the infant and after prior need for samples for clinical study had been satisfied. CD343+ cells were obtained after sorting nonadherent low density T lymphocyte depleted (NALT-) cells on a Dual Laser Flow Cytometer (Epics 753; Coulter Corp., Hialeah, FL) (25) . This population was >98% pure for cells expressing the CD34 antigen. CD343 + cells included the 20% of CD34 antigen expressing cells with the highest density distribution of CD34 antigens. This fraction is richest in stem/progenitor cells (23, 25). In some experiments, CD343+ cells were sorted or resorted using an auto-clone device (Coulter Corp.) into single wells, as a single cell or as 10 cells, containing 0.1 ml semisolid or liquid culture medium (25, 39) .
Colony Assay and Replating Experiments. Cultures contained IMDM (GIBCO BRL, Gaithersburg, MD), 1% methylcellulose, 30% FCS (Hyclone Laboratories, Inc., Logan, UT), 0.1 mM hemin (Eastman Kodak Co., Rochester, NY) and recombinant human (rhu) erythropoietin (Epo) (Amgen Corp., Thousand Oaks, CA), rhu steel factor (SLF), rhu 11,3, and rhu-GM-CSF (gifts from Immunex Corporation, Seattle, WA). Colonies were scored after incubation at 37°C, lowered (5%) Oz, and 5% CO 2 for 14 or 21 d. Replating experiments were performed after removing and dispensing a single colony into the same type of semisolid medium and growth factors as the primary culture (25) . Results are given as the mean or mean ± 1 SEM.
Retroviral Vector. The N2/ZipTKNEO (TKNEO) vector used in these studies has been described previously (37) . Neo phosphotransferase sequences are expressed in the sense orientation (rel-I Abbreviations used in this paper: BFU-E, burst forming unit erythroid; Epo, erythropoietin; GEMM, granulocyte erythroid macrophage megakaryocyte; HPP-CFC, high proliferative potential colony forming cells; NALT -, nonadherent low density T lymphocyte depleted ; rhu, recominant human; SLF, steel factor; TKNEO, NZ/ZipTKNEO.
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Gene Transduction into Isolated Stem/Progenitors ative to the 5' long terminal repeat-LTR) via the herpes simplex virus thymidine kinase promoter. GP+EnvAM 12TKNEO producer cells containing the TKNEO retroviral plasmid were cultured in IMDM containing 10% FCS. Viral-containing supernatant was collected by adding 10 ml of IMDM plus 20% FCS to confluent plates overnight. Harvested medium was filtered through 0.45 Am filters and stored at -80°C until use. The TKNEO virus was titered at 1 x 105 G418-resistant CFU/ml on NIH 3T3 cells. Retroviral Transduction Protocol. Two protocols were used in these studies. In the first protocol, NALT -or CD34 3 + cord blood cells (<5 x 105 cells/ml) were prestimulated with Epo (1 U/ml), SLF (50 ng/ml), IL-3 (200 U/ml), and GM-CSF (200 U/ml) at 37°C, 5% CO2, and 20% Oz for 40 h. 2 ml viral supernatant and 8 Ag/ml polybrene were added to cells 4 x at 2-h intervals. Cells were washed twice and assayed for colony formation or resorted into single wells containing either a single cell or 10 cells in the presence of 1 U/ml Epo, 50 ng/ml SLF, 200 U/ml IL-3, and 200 U/ml GM-CSF ± 1.5 mg/ml or 12 Ag/ml (dry weight) G418 . In the second protocol, single CD343 + cord blood cells were sorted into single wells containing 0.1 ml methylcellulose culture in the presence of cytokines as described above (25) . 3 or 4 d later, viral supernatant was added only once at 20 Al/well with polybrene (8 Ecg/ml) . G418 was added at 1.5 mg/ml or 12 Ag/ml 40 h after addition of viral supernatant .
To assay the temperature sensitivity of the virus preparation, 1000 NIH 3T3 cells were plated in 35-mm tissue culture dishes . Viral supernatant was added for 2.5 h with 8 Ag/ml polybrene, cells were washed, and fresh medium added with 1.5 mg/ml (dry weight) G418 .
Polymerase Chain Reaction (PCR) Analysis. Genomic DNA was isolated from individual colonies as described by others (40) with modification . Individual colonies were removed from primary or secondary methylcellulose culture or cells were removed after suspension culture and washed with 1 ml of PBS. Cell pellets were resuspended in the small volume of remaining PBS to which was added 200 Ell of a chelex 100 solution (41) . Cells were lysed by boiling for 5 min, chilled on ice for 5 min, and pelleted for 30 s at 2,800 g . 10 Al of supernatant from the lysate was used for PCR. As a positive control, DNA was obtained from cells incubated with viral supernatant that contained the TKNEO gene . As a negative control, DNA was obtained from cells incubated with supernatant not containing the TKNEO gene (mock control) . Two 27-bp oligonucleotides were used at 20 pmol in the PCR reaction . The PCR generated a 792-bp fragment of the TKNEO gene beginning with the 5' o4go-[27-by]5'CAAGATGGATTGCA000AGGTTCTCCG and ending with the 3' oligo-[27-by]5'CCAGAGT000GCTCAG-AAGAACTCGTC. Each sample was amplified for 30 cycles (94°C for 60 s to denature the DNA, 60°C for 2 min for primer annealing, and 72°C for 3 min for primer extension) as described (17) . 20 Al of reaction mixture was electrophoresed on a 1% agarose gel and this was photographed after ethidium bromide staining. Electrophoresed DNA was then transferred to Gene Screen Plus (Dupont-NEN, Boston, MA) and hybridized with [32 p]dCTP-labeled neo fragment . Hybridization was performed overnight at 42°C (17) . Filters were washed with 0.1% SDS, O.lx SSC (SSC = 0.15 M NaCl, 0.015 M sodium citrate) at 55'C, dried, and exposed to Kodak XAR film at -80°C.
Results
Gene Transduction into Early Hematopoietic Cells as Evaluated by G418R-Colonies. Before evaluating the transducing efficiency of TK-neo gene into purified populations of cord Table 1 . Colony Formation by G418'-NALT -or -CD34'' Cord Blood Cells" " Retroviral gene transfer was performed at <106 cells/ml. 2 ml of viral superntant with 8 Pg/ml polybrene was added for transduction as described in Materials and Methods. Sorted CD3" cells were transduced and either plated at 250 cells/ml, or subjected to a second sort in which 10 or 1 CD343 " cells were sorted into a single well . Cells were assayed for colony formation in the presence of Epo, SLF, IL-3, and GM-CSF ± G418 at 1.5 mg/ml (dry weight).
t The numbers in parentheses designate background growth of colonies from mock-infected cells growing in G418 and are based respectively on results of three, three, one, and one experiment with 5 x 104 NALT -, 250 CD343 *, 10 CD343 ' and 1 CD343 ' cell(s).
blood progenitor cells, progenitors present in a NALTpopulation of cells were used as targets. As shown in Table  1 , 25% of total progenitor cell-derived colonies were G418R. Over 50 G418R colonies were separately removed and each one was found by PCR analysis to contain the TK-neo gene. Similar studies were performed using populations of very highly enriched progenitor cells present in CD343+ populations of sorted cells in which at least 50-75% of the cells are CFU-GEMM, BFU-E, CFU-GM, and HPP-CFC (23, 25). Incubation of CD343 + cells with the TK-neo gene, followed by washing and plating at 250 cells/ml resulted in a TK-neo gene transduction efficiency similar to that noted for the NALT-population of cells (Table 1) . Interestingly, the apparent efficiency of gene transduction was even greater when the CD343+ cells that were incubated with viral supernatant and then washed were resorted as 10 or 1 CD343 + cell(s)/well (Table 1) . With one CD343 + cell/well, a 49% transduction efficiency was noted for G418R colonies with 45, 25, and 85% transduction apparent, respectively, for CFU-GEMM-, BFU-E-, and CFU-GM-derived colonies . Confirmation of the TK-neo gene in 96% of these G418R colonies (129 positive from 135 evaluated colonies) was obtained by PCR analysis of the cells from individual colonies. A breakdown of the different colony types showed that 98% (60/61) CFU-GEMM-, 89% (24/27) BFU-E-, and 97% (30/31) CFU-GM-G418R colonies contained the TK-neo gene. High efficiency transduction was also observed in cells growing in suspension from single sorted cells (8 of 8 wells positive by PCR). As seen in Table 1 , only a small percentage of G418R-HPP-CFC derived colonies were observed; 7 of 7 G418R-HPP-CFC colonies were documented by PCR analysis to contain the TK-neo gene.
Gene Table 2 , HPP-CFC-and CFU-GEMM-colonies were transduced at high efficiencies, respectively, of67-83% and 25-82%. Additionally four of eight wells seeded with a single CD343 + cell/well generated cells in suspension culture that contained the TK-neo gene. None of eight colonies derived from mock-infected CD343 + cells were found positive by PCR analysis for the TK-neo gene. Gene Transduction at the Single Isolated CD343+ Progenitor Cell Level. The experiments shown in Table 1 and 2 in which CD343 + cells were first incubated with viral supernatant containing the TK-neo gene and then resorted as a single CD343 + cell/well demonstrated that progenitor cells transduced with the TK-neo gene could proliferate and differentiate in the presence of growth stimulating cytokines but in the absence ofother progenitor or accessory cells at the start ofthe culture . We additionally wished to determine ifa single isolated CD343 + cell could be transduced with the TK-neo gene. CD343+ cells were sorted as a single cell/well and viral supernatant containing the TK-neo gene added as described in the Materials and Methods with the subsequent addition to these single cell cultures of either 1.5 mg/ml or 12 hg/ml G418 (Table 3) . Based on the findings that HPP-CFC in the absence of G418 could be transduced with the TK-neo gene at high efficiency (Table 2 ), but few HPP-CFC-G418R colo- Table 3 . G418R-Colonies Derived from Single CD343' Cord Blood Cells Transduced with Neo Gene at the Single Cell Level and Neo Gene Detection by PCR Analysis ofIndividual Primary G418R-Colonies nies formed in the presence of 1.5 mg/ml G418 (Table 1) , we had evaluated the sensitivity of HPP-CFC to inhibition by G418. This had not been previously done. HPP-CFC were found to be ultrasensitive to inhibition by G418 such that as little as 12 jAg/ml G418 was sufficient to greatly reduce colony formation by mock-infected HPP-CFC, while this concentration of G418 had little or no effect on CFU-GEMM, BFU-E, or CFU-GM . At 1.5 mg/ml G418, 4.2, 72.0, 82.0, and 97%, respectively, ofHPP-CFC, CFU-GEMM, BFU-E, and CFU-GM formed colonies (Table 3 A). 26 of 27 of these G418R-colonies were positive by PCR analysis for the TK-neo gene (Table 3 B, Fig. 1 ). At 12 p.g/ml G418, 85% of the HPP-CFC survived to form colonies (Table 3 A) and 11 of 12 of these colonies were positive to PCR analysis for the TK-neo gene (Table 3 B, Fig. 1) . Also, as shown in Table  3 B, suspension cultures derived from single progenitors incubated with virus supernatant containing the TK-neo gene and grown in the presence of 1.5 mg/ml G418 were positive in 6 of 6 wells for the TK-neo gene by PCR analysis .
Since we found that it was not possible to wash single cells after sorting the cells into single wells without losing the cells, the single sorted cells were not washed free of the viral supernatant containing the TK-neo gene. Other means were thus used to evaluate whether the virus added to the single cells was transducing the TK-neo gene into the original sorted progenitor cell, or whether the possibility existed that immediate or subsequent daughter cells were being infected after the progenitor or daughter cells had divided. To this end, we first evaluated the transducing stability of the viral supernatant containing the TK-neo gene at 37°C (incubation temperature) . Viral supernatant was incubated at 37°C for 6, 24,
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Gene Transduction into Isolated Stem/Progenitors and 48 h and these treated viral samples were compared to viruses not subjected to 37°C for their capacity to transduce NIH 3T3 cells as assessed by the growth of G418R (1 .5 mg/ml)-NIH 3T3 colony forming cells. Virus incubated for 6, 24, and 48 h at 37°C, respectively, produced 50, 0, and 0 G418R colonies compared with the >150 colonies formed from NIH 3T3 cells incubated with nonheat-treated virus. Thus, the transducing capacity of the virus was completely lost between 6 and 24 h incubation of the virus at 37°C . Examination of CD343+ cells sorted as a single cell/well demonstrated that at a time that was equivalent to 24 h after CFU-GEMM can be replated with high efficiency (30, 31) . Single colonies in primary plates derived from single CD343+ HPP-CFC/well and incubated with viral supernatant containing the TK-neo gene and cultured with 12 hg/ml G418, and single colonies from single CD343+ CFU-GEMM/well incubated with viral supernatant containing the TK-neo gene and cultured with 1.5 mg/ml G418 were replated into secondary culture plates. 50 primary HPP-CFC-colonies were individually placed into secondary dishes with a replating efficiency of 62%. Secondary plates contained HPP-CFC-colonies, which were at least as large as the primary colonies from which they were derived, containing tens of thousands of cells, and also CFU-GM colonies. 98 primary CFU-GEMM colonies were individually placed into secondary dishes with a replating efficiency of69%. Secondary plates included CFU-GEMM-, BFU-E-, and CFU-GM-colonies. Results in Table  4 and Fig. 2 demonstrated that the TK-neo gene was detected in 100% of the secondary colonies demonstrating stable integration into subsets of stem/progenitor cells that have replating capacity.
Discussion
Gene therapy may be an option for the treatment of certain genetic disorders (3, 4) and in this context retroviral containing vectors have been used to transduce genes into hematopoietic stem and progenitor cells (1, 2, (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) 37) . Cord blood stem/progenitor cells have been used to clinically transplant and correct a number of blood disorders (32) (33) (34) (35) (36) , and this source of cells may be especially useful for gene therapy in an autologous situation for newborns and young children . The use of cord blood cells for such purposes is highlighted by the enhanced frequency and quality of immature stem/progenitor cells in cord blood compared to adult bone marrow (25-31), and the more efficient transduction of progenitors and long-term culture initiating cells in relatively unseparated cord blood by retroviral-mediated gene transfer (37) . It is our feeling that the future of gene therapy in the setting of stem/progenitor cells will not only entail the use of highly enriched fractions of these cells, but also, as technology for characterizing and isolating subsets of these cells based on their self-renewal, proliferative, and lineage differentiation capacities becomes available, it will be these isolated and distinct subsets that will be used as target cells for this purpose. Currently, antigenic profiles available for human stem-progenitor cells only allow for very small degrees of separation of subsets of these cell populations (23, 25).
In the present study, we have not only demonstrated a very high degree ofefficiency of stable gene transduction into very highly purified stem/progenitor cells from cord blood, but we have shown this capability at the level of a single isolated CD343+ cell. This opens up the possibility in the future that as different subtypes of stem/progenitors become recognizable antigenically, single such cells can be efficiently transduced with genes. That the genes were put into immature cells is suggested by the fact that the cells containing the genes were stimulated to proliferate by multiple growth factors that are necessary to induce early subsets of cells to grow (25, 39, 42) , and by the extensive replating capacity of the transduced HPP-CFC and CFU-GEMM . The high efficiency of gene transduction may relate to the combination of potent growth factors used in the pretreatment phase, and also the use of few cells per volume of vector-containing supernatant . An especially high transduction efficiency was apparent when single CD343 + cells were used. Interestingly, we had to use no G418, or low amounts of G418 to demonstrate the high rate ofgene transduction ofHPP-CFC, due to the hypersensitivity ofHPP-CFC to inhibition by G418. Our studies demonstrate that high efficiency gene transduction is feasible in the absence of vector-producing stromal cells, an extremely important consideration if one wishes to use the transduced cells for transplantation without worry of potential graft vs. host reactions that may occur from infusion into patients of contaminating vector-producing stromal cells. Also, our studies demonstrate high efficiency gene transduction in the complete absence of accessory cells as rigorously determined by the single cell studies.
Engraftment and repopulation of the hematopoietic system appears to require marrow repopulating cells as well as more mature short-term engrafting cells. Unfortunately, there is no assay yet available that definitively characterizes human marrow repopulating cells. Stem as well as progenitor cell populations entail a hierarchy of cells within each category from more immature to more mature. A human cell that has the expected characteristics ofearly subsets of stem cells has been identified (43) but whether this human cell population contains long-term marrow repopulating cells remains to be determined. The cells assessed in this current report are not considered to be long-term marrow repopulating cells, but HPP-CFC and CFU-GEMM can be considered to be at least subsets ofmore mature stem cells based on the extensive replating capacity of the primary colonies derived from these cells (25, 30, 31) . From bone marrow transplantation studies using CD343+ cells (34) it is likely that our population of sorted CD343 + cells contain long-term marrow engrafting cells . It remains to be determined, as soon as an appropriate assay is available, whether the human marrow repopulating cells are also transducible with genes at the efficiency noted in our study for HPP-CFC, CFU-GEMM, BFU-E, and CFU-GM .
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